In particular, CPT1A has found to be overexpressed in most ovarian cancer cell lines and primary ovarian serous carcinomas, to correlate with poor overall survival of ovarian cancer patients, and to be upregulated in cells cultured in suspension namely mimicking in vitro anoikis resistance9,13. The gene discussed is CPT1A; the disease is ovarian carcinoma.